Coya Therapeutics Inc — Cash Flow (NASDAQ:COYA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -7.24 M-11.19 M-10.29 M-10.74 M -10.74 M Cash from investing activities -525 K-543.19 K-25 K-1.16 M — Cash from financing activities 9.36 M38.43 M16.03 M20.39 M 20.39 M Free cash flow -7.24 M-11.19 M-10.29 M-10.74 M -10.74 M

뉴스

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?

코야 테라퓨틱스, H.C. 웨인라이트 ’매수’ 등급 재확인, 목표가 $18

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

코야 테라퓨틱스, 1110만 달러 규모 사모 자금 조달

Coya Therapeutics secures $11.1 million in private placement

코야 테라퓨틱스, 2026년 ALS 및 FTD 임상시험 진행

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. 웨인라이트, 코야 테라퓨틱스에 ’매수’ 등급 재확인, 목표가 18달러

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)

코야 테라퓨틱스, H.C. 웨인라이트 ’매수’ 등급 재확인